Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Satoru, Kosugi"'
Autor:
Yutaka Shimazu, Junya Kanda, Satoru Kosugi, Tomoki Ito, Hitomi Kaneko, Kazunori Imada, Yuji Shimura, Shin-ichi Fuchida, Kentaro Fukushima, Hirokazu Tanaka, Satoshi Yoshihara, Kensuke Ohta, Nobuhiko Uoshima, Hideo Yagi, Hirohiko Shibayama, Ryosuke Yamamura, Yasuhiro Tanaka, Hitoji Uchiyama, Yoshiyuki Onda, Yoko Adachi, Hitoshi Hanamoto, Ryoichi Takahashi, Mitsuhiro Matsuda, Takashi Miyoshi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Novel therapeutic drugs have dramatically improved the overall survival of patients with multiple myeloma. We sought to identify the characteristics of patients likely to exhibit a durable response to one such drug, elotuzumab, by analyzing
Externí odkaz:
https://doaj.org/article/f9f360c7a7b8496ea74ce32ada6c5c4d
Autor:
Aya Nakaya, Hirohiko Shibayama, Nobuhiko Uoshima, Ryosuke Yamamura, Satoshi Yoshioka, Kazunori Imada, Yuji Shimura, Masaaki Hotta, Toshimitsu Matsui, Satoru Kosugi, Hitoshi Hanamoto, Hitoji Uchiyama, Satoshi Yoshihara, Shin-ichi Fuchida, Yoshiyuki Onda, Yasuhiro Tanaka, Kensuke Ohta, Mitsuhiro Matsuda, Junya Kanda, Adachi Yoko, Miki Kiyota, Eri Kawata, Ryoichi Takahashi, Kentaro Fukushima, Hirokazu Tanaka, Hideo Yagi, Teruhito Takakuwa, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Masayuki Hino
Publikováno v:
Leukemia Research Reports, Vol 20, Iss , Pp 100395- (2023)
To evaluate the specific prognostic value of CAs, we conducted an analysis of 923 symptomatic multiple myeloma patients. Among this cohort, 480 patients had complete data set of high-risk CAs by interphase fluorescent in situ hybridization at diagnos
Externí odkaz:
https://doaj.org/article/82b016d7b6d64623a8db970348a6c492
Autor:
Yutaka Shimazu, Junya Kanda, Hitomi Kaneko, Kazunori Imada, Ryosuke Yamamura, Satoru Kosugi, Yuji Shimura, Tomoki Ito, Shin-ichi Fuchida, Hitoji Uchiyama, Kentaro Fukushima, Satoshi Yoshihara, Hitoshi Hanamoto, Hirokazu Tanaka, Nobuhiko Uoshima, Kensuke Ohta, Hideo Yagi, Hirohiko Shibayama, Yoshiyuki Onda, Yasuhiro Tanaka, Yoko Adachi, Mitsuhiro Matsuda, Masato Iida, Takashi Miyoshi, Toshimitsu Matsui, Ryoichi Takahashi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Daratumumab is one of the most widely used treatments for relapsed/refractory multiple myeloma (MM) patients. However, not all patients achieve a lasting therapeutic response with daratumumab. Objectives: We hypothesized that a durable re
Externí odkaz:
https://doaj.org/article/de0e47159d65497ba083e4d809b5a35a
Autor:
Aya Nakaya, Hirohiko Shibayama, Eiji Nakatani, Yuji Shimura, Satoru Kosugi, Hirokazu Tanaka, Shin‐Ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, Hitomi Kaneko, Kazunori Imada, Kensuke Ohta, Tomoki Ito, Hideo Yagi, Satoshi Yoshihara, Masayuki Hino, Chihiro Shimazaki, Akifumi Takaori‐Kondo, Junya Kuroda, Itaru Matsumura, Yuzuru Kanakura, Shosaku Nomura
Publikováno v:
eJHaem, Vol 2, Iss 4, Pp 765-773 (2021)
Abstract A total of 129 symptomatic patients with multiple myeloma (MM) who underwent high‐dose chemotherapy with autologous stem cell transplantation (HDT/ASCT) were analyzed. The 4‐year overall survival (OS) of patients with maintenance (n = 82
Externí odkaz:
https://doaj.org/article/fca8d9086da64417a2e3ae2412495e6f
Autor:
Yoshiyuki Onda, Junya Kanda, Hitomi Kaneko, Yuji Shimura, Shin-ichi Fuchida, Aya Nakaya, Tomoki Itou, Ryosuke Yamamura, Hirokazu Tanaka, Hirohiko Shibayama, Yutaka Shimazu, Hitoji Uchiyama, Satoshi Yoshihara, Yoko Adachi, Mitsuhiro Matsuda, Hitoshi Hanamoto, Nobuhiko Uoshima, Satoru Kosugi, Kensuke Ohta, Hideo Yagi, Yuzuru Kanakura, Itaru Matsumura, Masayuki Hino, Shosaku Nomura, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Little is known about the real-world survival benefits and safety profiles of carfilzomib–lenalidomide–dexamethasone (KRd) and carfilzomib–dexamethasone (Kd). Methods: We performed a retrospective analysis to evaluate their efficacy
Externí odkaz:
https://doaj.org/article/c8a169335f1a487791719eaf9c1c6082
Autor:
Aya Nakaya, Hideo Yagi, Hitomi Kaneko, Satoru Kosugi, Toru Kida, Yoko Adachi, Hirohiko Shibayama, Takae Kohara, Yuri Kamitsuji, Shin-ichi Fuchida, Nobuhiko Uoshima, Eri Kawata, Hitoji Uchiyama, Yuji Shimura, Takayuki Takahashi, Fumiaki Urase, Kensuke Ohta, Tsuneyoshi Hamada, Kazue Miyamoto, Masayuki Kobayashi, Maki Shindo, Hirokazu Tanaka, Chihiro Shimazaki, Masayuki Hino, Junya Kuroda, Yuzuru Kanakura, Akifumi Takaoari-Kondo, Shosaku Nomura, Itaru Matsumura
Publikováno v:
Leukemia Research Reports, Vol 10, Iss , Pp 7-10 (2018)
We retrospectively analyzed twenty-six patients with primary plasma cell leukemia (pPCL) registered from May 2005 until April 2015 by the Kansai Myeloma Forum. Twenty patients received novel agents (bortezomib or lenalidomide), and their median survi
Externí odkaz:
https://doaj.org/article/60725e003e734cd185128c760bbe013a
Publikováno v:
Internal Medicine. 62:1247-1248
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6699203b57c9cd644155d3ad76113b
https://doi.org/10.2169/internalmedicine.0496-22
https://doi.org/10.2169/internalmedicine.0496-22
Autor:
Tetsuhisa Kitamura, Masashi Nakagawa, Jun Ishikawa, Ryoto Sakaniwa, Yasuhiro Moriyama, Hirohiko Shibayama, Yasuhiko Azenishi, Tsuyoshi Kamae, Satoru Kosugi, Kenji Nozaki, Takahiro Karasuno, Hiroyuki Sugahara, Manabu Kawakami, Shuji Ueda, Masato Iida
Publikováno v:
International Journal of Hematology. 114:217-221
High pre-treatment serum soluble interleukin-2 receptor (sIL-2R) levels are associated with poor overall survival (OS) of patients with newly diagnosed follicular lymphoma (FL). We evaluated the usefulness of pre-treatment sIL-2R levels in selecting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27ce2294a05dd9353f965859f6e797a0
https://doi.org/10.1007/s12185-021-03151-5
https://doi.org/10.1007/s12185-021-03151-5
Autor:
Itaru Matsumura, Junya Kuroda, Junya Kanda, Shosaku Nomura, Yuji Shimura, Nobuhiko Uoshima, Jun Ishikawa, Katsuya Wada, Masayuki Hino, Yuzuru Kanakura, Yutaka Shimazu, Hitomi Kaneko, Akifumi Takaori-Kondo, Kansai Myeloma Forum Investigators, Tomoki Ito, Chihiro Shimazaki, Yoshiyuki Onda, Satoru Kosugi, Toru Kida, Ryosuke Yamamura, Shin-ichi Fuchida, Hirohiko Shibayama, Takae Kohara, Satoshi Yoshihara, Aya Nakaya, Miki Kiyota, Hideo Yagi, Kensuke Ohta, Kazunori Imada, Hirokazu Tanaka
Publikováno v:
International Journal of Hematology. 112:435-438
We retrospectively analyzed the clinical features and outcomes in a real-world cohort of adolescents and the young adult (AYA) patients (age between 16 and 39 years) with symptomatic multiple myeloma (MM) registered with the Kansai Myeloma Forum. 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c49f3efca089c372ecde178c5e6fcd
https://doi.org/10.1007/s12185-020-02996-6
https://doi.org/10.1007/s12185-020-02996-6
Autor:
Toru Kida, Hitomi Kaneko, Toshimitsu Matsui, Miki Kiyota, Shin-ichi Fuchida, Shosaku Nomura, Takae Kohara, Kansai Myeloma Forum Investigators, Nobuhiko Uoshima, Ryoichi Takahashi, Yoko Adachi, Kazunori Imada, Kensuke Ohta, Satoru Kosugi, Hirokazu Tanaka, Mitsuhiro Matsuda, Masato Iida, Akifumi Takaori-Kondo, Junya Kanda, Hideo Yagi, Hitoji Uchiyama, Masayuki Hino, Hirohiko Shibayama, Yuji Shimura, Yuzuru Kanakura, Katsuya Wada, Junya Kuroda, Takahiro Karasuno, Aya Nakaya, Itaru Matsumura, Maki Shindo, Chihiro Shimazaki
Publikováno v:
International Journal of Hematology. 112:666-673
We retrospectively analyzed 51 patients with solitary plasmacytoma diagnosed from October 2002 to September 2018 from a cohort of 3575 patients with plasma cell dyscrasias registered in the Kansai Myeloma Forum. Twenty-seven patients had solitary bon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09e23912ba2625709c582de2d7e570ac
https://doi.org/10.1007/s12185-020-02961-3
https://doi.org/10.1007/s12185-020-02961-3